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It has become increasingly apparent that the regulation of immune responsiveness 
is accomplished by a variety of processes. Suppressor cells have recently emerged as a 
major element of this regulation. These cells may act either by directly suppressing 
responsive cells or by liberating soluble-suppressor factors. Not only have suppressor 
cells been found to be active in the regulation of ongoing immune responses, but they 
have also been found in association with the tolerant state to a number ofT-dependent 
and  T-independent  antigens,  including  synthetic  antigens  (1,  2),  polysaccharide 
antigens  (3),  and  soluble  protein  antigens,  human  serum  albumin  (HSA) 1 (4)  and 
human  gamma globulin  (HGG)  (5-7).  Although  the  role of suppressor cells in  the 
establishment of tolerance has been convincingly demonstrated in some unresponsive 
states (8-11), this relationship remains to be proven in many systems. Several workers 
have reported  that  unresponsiveness  to  protein  antigens  can  be established  in  the 
absence of detectable suppressor ceils in normal animals (12-17), neonatal mice (18), 
adult  thymectomized,  X-irradiated,  bone-marrow  reconstituted  mice  (4,  13),  and 
athymic nude  mice  (19-21).  Although  antigen-specific-suppressor cells may not  be 
necessary for the establishment or maintenance of these tolerant states, their presence 
in antigen-primed animals (22,  23)  suggests that they may play a  regulatory role in 
immune responsiveness to these protein antigens. 
The presence of suppressor cells and the degree of their activity can be modulated 
by a  number of factors. Suppressor cells acting directly upon  helper T  cells can be 
induced  by  other  T  ceils  (24).  In  addition,  HGG-specific-suppressor cells  can  be 
inhibited  or  inactivated  by  treatment  with  antisera  specific  for  surface  antigens 
present on suppressor cells, such as antigens coded for in the 1-J region of 1-1-2 (25), 
and with antisera directed against cell-surface antigens on subsets of T  lymphocytes 
such as Lyt-2 (25,  26)  and Thy-1  (6,  25)  antigens.  Pharmacological agents known to 
serve as adjuvants may increase immune responsiveness by inhibiting the generation 
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or action of suppressor  cells.  Agents that  have  been demonstrated  to interfere  with 
suppressor  cells  affecting humoral  or cellular-immune  responses  include  cyclophos- 
phamide  (27-31),  corticosteroids  (32-35),  indomethacin  (36),  and  colchicine  (Col) 
(37). Sublethal doses of irradiation  can also increase immune responsiveness  (38-41), 
possibly by disturbing cellular division of radiosensitive-suppressor cells. 
Experimental  abrogation of suppressor-cell activity allows investigation of the role 
of these  cells  in  the  regulation  of the  immune  response  and  the establishment  and 
maintenance of immunologic unresponsiveness in the absence of suppressor cells. The 
goals of this  paper  are  to demonstrate  pharmacological  interference  with  both  the 
induction  and  expression  of antigen-specific-suppressor  cells  for the soluble  protein 
antigen HGG by Col and to explore the resulting tolerant state to HGG. The effects 
of this  agent  are  examined  in  hopes  of elucidating  the  cellular  and  subcellular 
dynamics  of the  generation  and  action  of suppressor  cells  and  the  induction  and 
duration of immunologic unresponsiveness to a protein antigen in the absence of these 
cells. 
Materials  and Methods 
Animals.  Male  A/J  mice  were  purchased  from  The Jackson  Laboratory  (Bar  Harbor, 
Maine)  at 4- to 5-wk old. They were maintained  on Wayne Lab Blox F6 (Allied  Mills,  Inc., 
Chicago, I11.) and acidified water ad lib. All mice were housed five to a cage. Mice ranging in 
age from 8 to 9 wk were utilized in these experiments. These mice had a mean body weight of 
24.4  ±  0.4 g. 
Chemicals.  Phenol-extracted bacterial lipopolysaccharides (LPS) from Escherichia coli 0111: 
B4 lot 614378 were purchased from Difco Laboratories, Detroit, Mich. When pharmacological 
agents were injected, the dosage per mouse was: 25/~g of LPS injected i.v. 3 h after antigenic 
challenge, 25/xg of colchicine (~  1.0 mg/kg)  (Calbiochem-Behring Corp., American Hoeehst 
Corp., San Diego, Calif.)  injected i.v. 2-3 h after exposure to tolerogen or antigen, or 2.5 mg of 
cyclophosphamide (~  100 mg]kg) (Mead Johnson Laboratories, Evansville, Ind.) injected i.v. 
2 d before antigen. These agents were diluted in pyrogen-free 0.15 M sterile NaCI. 
Antigens and Immunization.  Cohn  fraction  II lot  RC-104 of human  plasma  was obtained 
through the courtesy of the American Red Cross National Fractionation Center with the partial 
support of the National Institutes of Health grant HE 13881 HEM. Human gamma globulin 
was purified  from this  material  by column chromatography on DEAE-cellulose in 0.01  M 
phosphate buffer, pH 8.0. Immunogenic, heat-aggregated HGG (AHGG) was prepared from 
the DEAE-purified HGG as described previously (42)  by using a  modification of Gamble's 
method (43). Mice received a primary injection of 400/.tg of AHGG i.v. into the lateral caudal 
vein followed in some cases by a secondary injection of the same amount of antigen intraperi- 
toneally  10 d  later.  Sheep erythrocytes (SRBC)  were purchased  from Colorado Serum  Co., 
Denver,  Colo.  Primary  injection  of 10  s  SRBC  was  given  6  d  before assessment  of plaque- 
forming cells (PFC). 
Induction of Tolerance and Suppressor Cells.  Tolerogenic,  deaggregated  HGG  (DHGG)  was 
prepared by ultracentrifugation of DEAE-purified HGG for 150 min at  150,000 g to remove 
aggregated material as previously described (17). The upper quarter of the centrifuged solution 
was diluted and injected into mice i.p. Each mouse received 2.5 mg of DHGG. The spleens of 
mice tolerized 10 d previously served as the source of suppressor cells. 
Irradiated Recipients.  Recipients for adoptive transfer were irradiated 2-3 h before reeonsti- 
tution.  Mice placed in an aluminum chamber in a  Gamma Cell 40 small animal  irradiator 
(Atomic Energy of Canada, Ltd., Ottawa, Canada)  received 900 roentgen (R) of whole body 
irradiation  from  a  XSTCe source emitting  a  central  dose  of  106  R  per  rain.  Reconstituted 
recipients received  100/~g of gentamicin (Schering Pharmaceutical Corp., Kenilworth, N. J.) 
i.p.  diluted  in 2.7% glucose in saline on the day of irradiation and again 3 d  later and were 
caged in groups of two to avoid the problem of early irradiation  death, presumably due to 
bacterial infection. 
Adoptive Transfer Assay for Suppression.  The spleen cells of normal and tolerant mice that were 1170  INTERFERENCE WITH SUPPRESSOR CELLS BY COLCHICINE 
adoptively transferred into lethally irradiated animals were obtained as described previously 
(20).  Briefly,  spleens  were  aseptically removed and  sterilely  grated  through  350  #m  mesh 
stainless steel screens into balanced salt solution (BSS) supplemented with 100 U of penicillin 
and 100gag of streptomycin per ml. The cell suspensions were washed three times in BSS, and 
70 ×  10  viable spleen cells were injected i.v. via a lateral caudal vein into irradiated recipients. 
Animals receiving more than one cell type received  sequential  injections.  Primary antigenic 
challenge was delivered i.v. immediately after cellular reconstitution and was followed  10 d 
later by a secondary injection of AHGG i.p. 5 d after the secondary challenge, the recipients' 
spleens were removed and individually assayed for PFC. 
Hemolytic Plaque Assay.  PFC were assayed by a slide modification of the hemolytic plaque 
assay (44). Cohn Fraction II HGG at a concentration of 20 mg/ml was covalently coupled to 
goat erythrocytes (GRBC) (Colorado Serum Co.) by using water-soluble carbodiimide (1-ethyl- 
3-[3-dimethylaminopropyl]carbodiimide  hydrochloride) (Calbiocbem-Behring Corp.) (45). This 
HGG was previously absorbed against GRBC. Plaques were developed with guinea pig serum 
(Pel-Freez Biologicals Inc., Rogers, Ark.) as a source of complement, and indirect plaques were 
amplified with rabbit anti-mouse IgG serum previously absorbed against HGG and GRBC. 
Statistical Methods.  Results of the plaque assay are expressed  as the mean number of PFC 
per 106 spleen cells :t= the standard error corrected for the background response to the indicator 
erythrocytes. Data were analyzed statistically with Student's t test. The percent suppression was 
determined as follows: 
percent suppression 
--  (1- 
mean PFC/IO  6 for recipients of normal and tolerant spleen cells~ 
mean PFC/10  e for recipients of normal spleen cells alone  ,] ×  100. 
Results 
Adjuvant Activity of Pharmacological Agents.  To assess the effectiveness of two phar- 
macological agents previously reported to mediate adjuvant activity in other immu- 
nologic systems, mice were injected with 2.5 mg of cyclophosphamide 2 d  before, or 
25 pg of Col  at  the time of, immunization  with either  100  or 400 #g of antigenic 
AHGG. Some mice also received 10  s SRBC. The results of the PFC responses of these 
animals 6  d  after antigenic exposure are presented in Table I. Both of these agents 
stimulated a  marked increase in the number of PFC in spleens of animals given the 
lower dose of HGG.  However, the  response of mice to 400 #g of AHGG was  less 
susceptible to augmentation by Col than was the response to 100 #g of antigen. The 
primary response to SRBC was also increased by the preadministration of cyclophos- 
phamide. Thus, both cyclophosphamide and Col promoted an adjuvant increase in 
the  primary  PFC  response  in  vivo  to  the  soluble  protein  antigen  HGG  under 
appropriate conditions. 
Temporal Relationship between Col and Antigen Injection.  The possibility that the failure 
to detect an increase in PFC to HGG in animals given Col and the higher dose of 400 
pg  of AHGG  was  a  result  of the  inappropriate  timing  of the  Col  injection  was 
investigated. Mice immunized with either 100 or 400 #g of AHGG were injected with 
Col at various days ranging from  1 d  before antigen  through  5  d  after antigen.  As 
illustrated inFigs.  1 and 2, 400 #g of AHGG alone stimulated a greater PFC response 
at 6 d  after immunization than did  100 #g of antigen.  Furthermore, the injection of 
Col from 1 d before to 1 d after 100#g of antigen stimulated a marked increase in the 
number of PFC detected to HGG (Fig.  1). On the contrary, Col was not able to exert 
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TABLE  I 
Adjuvantidty of Col and Cydophosphamide on Prima~y Immune Responses 
Exp.  Treatment*  Antigenic.~ challenge 
Mean PFC/10  s  +  SE to: 
HGG§  SRBC[I 
100#gAHGG  581  :t:  149 
Col  100 ~g AHGG  1591:1:334 
--  400/~g AHGG  954 ±  398 
Col  400 #g AHGG  946  3=  232 
--  I~#gAHGG  142  ±  25  43  ±  12 
+  SRBG 
G~loph~phami~  1~ #gAHGG  917  ±440  241  ±  23 
+  SRBC 
* 25 #g of Col was injected i.v. 2 h  after antigen. 2.5 mg of eyclophosphamide was injected i.v. 2 d  before 
antigen. 
:~ 100 or 400 #g of AHGG was injected i.v., and individual spleens were plaqued 6 d  later. In exp. II, both 
100 #g of AHGG and 108 SRBC were given in separate i.v. injections. 
§ Indirect PFC. 
II Direct PFC. 
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FIG.  1.  Adjuvant effect of colchicine on the primary response to a  low dose of HGG.  100 #g of 
AHGG was injected i.v. on day 0.  25 pg of Col was injected i.v. on  various days before or after 
antigen, and PFC were assayed on day 6. The mean ±  SE is presented. 
of the temporal relationship between the injection of antigen and Col (Fig. 2). The 
data in Fig.  1 are in agreement with previous reports indicating that Col must be 
given in close proximity to antigenic challenge to serve as an effective adjuvant (46, 
47).  Additionally, these  data suggest  that  the  injection of Col  within  1 d  of the 
assessment of the immune response  does not significantly decrease the number of 
antigen-specific PFC detected. Therefore, both the antigenic dose and the temporal 
relationship between the injection of antigen and Col appear to be crucial for the 
expression of colchicine-mediated adjuvanticity. 
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Fzo. 2.  Lack of adjuvanticity of colchicine with high antigen dose. The data were obtained as 
described  in Fig.  1 except that 400 #g of AHGG was injected on day 0. 
TABLe  II 
Abrogation of the Generation of Suppressor Cells to HGG by Col 
Spleen cells transferred* 
PFC/t06 to  Percent 
Group  Tolerant  Normal  Antigenic  HGG Mean  4-  suppres- 
challenge§  SE  sion[[ 
DHGG +  DHGG  Col~ 
1  70  X  10  e  --  --  AHGG  8 +  6  -- 
2  70 X  106  --  70 X  10  n  AHGG  192 4- 38  0 
3  --  --  70  ×  106  AHGG  191  +  33  -- 
4  --  70 ×  10  s  70 ×  10  s  AHGG  80 4-  14  58 
5  --  70  ×  106  --  AHGG  4  4-  2  -- 
* 900 R irradiated recipients were reconstituted with either normal spleen cells or spleen cells from tolerant 
mice that had received 2.5 mg of DHGG 10 d earlier or both. 
2.5 mg of DHGG was injected i.p. and followed 3 h later with 25 #g of Col, as indicated. 
§ Reconstituted mice received 400 #g of AHGG on the day of cell transfer and again  10 d later and were 
assayed 5 d after secondary  challenge.  The mean +  SE of the number of indirect PFC to HGG from five 
to eight mice is presented. 
[1 See Materials and Methods. 
possibility that Col may act as an adjuvant  for soluble protein antigens by interfering 
with the generation of antigen-specific suppressor cells as previously demonstrated  for 
the  synthetic  copolymer  L-glutamic  acidS°-L-tyrosine  5°  (37),  the  effects of Col  upon 
HGG-specific  suppressor  cells were  assessed.  The  basic  protocol  for  measuring  sup- 
pressor-eell activity to HGG  involved the adoptive transfer of 70  ×  106 viable spleen 
cells  containing  suppressor  cells  from  mice  tolerized  10  d  previously  with  DHGG 
together with 70  ×  106 viable spleen cells from normal animals into lethally irradiated, 
syngeneic recipients (17, 48). Control groups received either normal or tolerant spleen 
cells alone. In the experiments assessing interference with the induction of suppressor 
cells, all recipients were challenged with 400 #g of AHGG  on  the day of cell transfer 
and  again  10  d  later,  and  the  PFC  response  was  assessed  5  d  after  the  secondary 
challenge. 
To  investigate  the  ability  of Col  to  abrogate  the  generation  of suppressor  cells 
during the induction of tolerance to HGG, mice were injected with 2.5 mg of tolerogen 
(DHGG)  followed  3  h  later  by  25 #g of Col  injected  i.v.  (Table  II and  Fig.  3).  As 1173 
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Fxc.  3.  Inhibition of induction of suppressor cells with Col. The suppressive activity of tolerant 
spleen cells from donors tolerized 10 d before transfer was assayed by adoptive transfer. As indicated, 
some  donors  were  treated  with  25  #g  of (2ol  2  h  after  injection  of DHGG.  The  percent  of 
unresponsiveness (or suppression) was calculated as described in Materials and Methods. Suppression 
was  calculated  from  experimental  recipients  receiving  both  normal  and  tolerant  spleen  cells. 
Unresponsiveness was calculated from experimental recipients of tolerant cells alone. The mean  :t: 
SE of five to six recipients are presented. 
demonstrated in Table  II,  the injection of Col  had  no effect on  the  induction of 
tolerance to HGG. Spleen  cells from mice treated with Col and DHGG  (group  1) 
were  unresponsive  on  adoptive  transfer  as  were  cells  from  animals  treated  with 
tolerogen  alone  (group  5).  The  injection of DHGG  generated  suppressor  cells  as 
evidenced by the depressed response of recipients receiving both tolerant  (DHGG- 
treated) and normal spleen cells (group 4) when compared with the response of the 
recipients of normal spleen cells alone (group 3). However, mice injected with Col 3 
h after the injection of DHGG possessed no detectable suppressor cells in their spleens 
as illustrated by the response of animals receiving spleen cells from both Col-treated 
tolerant and normal mice (group 2). On the contrary, the recipients ofceUs from both 
DHGG and Col-treated mice and normal mice showed responses equal to (Table II) 
or exceeding (Fig. 3) those of recipients of normal cells alone. The demonstration in 
Fig. 3 of heightened responsiveness in the recipients of cells from normal and tolerant 
mice not containing detectable suppressor cells compared to recipients of normal cells 
alone is in agreement with previqusly published data on the responsiveness of mixtures 
of tolerant but nonsuppressive spleen cells and normal cells (17). 
Interference with the Expression of Suppressor Cells by Col.  The demonstration that the 
injection of Col 3 h  after tolerization inhibits the generation of HGG-specifie sup- 
pressor  cells  was  extended  by  assessing  the  ability  of Col  to  interfere  with  the 
expression of suppressor cells.  To investigate the effects of Col on the activities of 
suppressor cells previously generated by the injection of DHGG, spleen eeUs from 
animals tolerized  10 d  previously were transferred together with spleen cells from 
normal mice into irradiated recipients. These recipients were injected with 400 ~g of 
AHGG  i.v., and  3  h  after this antigenic challenge one-half of the recipients were 1174  INTERFERENCE  WITH  SUPPRESSOR  CELLS  BY  COLCHICINE 
TABLE  III 
Interference with the Expression of Suppressor Cells by Col 
Spleen cells transferred*  Antigenic chal-  PFC/10 6 to  Percent 
Group  lenge:~  HGG§  suppres- 
Tolerant  Normal  sion 
1  70  ×  106  --  AHGG  +  Col  7  3=  4  -- 
2  70  X  10  s  70  X  106  AHGG  +  Col  298  3=  56  0 
3  --  70  x  106  AHGG  +  Col  265  3=  31  -- 
4  70  x  106  --  AHGG  2  3=  1  -- 
5  70  X  I0  s  70  X  10  e  AHGG  86 ±  21  47 
6  --  70  X  106  AHGG  162  3=  37  -- 
* See Table II, footnote*. 
:~ Recipients were challenged as described in Table II, foomote§, except that 25 #g of Col 
was injected i.v. 3 h  after the primary antigenic challenge, as indicated. 
§ The  mean  3=  SE  of indirect PFC  to  HGG  from  duplicate experiments containing 5-10 
mice per group is presented. 
injected with 25 #g of Col.  The secondary response  of these mice was assessed by 
injecting 400 #g of AHGG alone 10 d  after the primary injection and plaquing 5 d 
after this secondary challenge. Table III demonstrates that the addition of Col to the 
primary antigenic challenge abolishes  the activity of the suppressor  cells present in 
the tolerant spleen-cell population (group 2). However, Col injected at this time does 
not terminate the unresponsive state in tolerant spleen  cells transferred 10 d  after 
tolerization (group 1). The adjuvant effect of Col can be detected by comparing the 
responsiveness  of transferred normal spleen  cells challenged with antigen and Col 
(group 3) or challenged with antigen alone (group 6). This adjuvant increase  is due 
presumably to the  inhibition of the  generation of suppressor  cells  in  the  normal 
spleen-cell population. However, the increased responsiveness of normal spleen cells 
challenged with antigen and Col does not account for the abolition of supp~r-cell 
activity found in colchicine-treated recipients of normal and tolerant spleen cells. 
Inability  of Col to Interfere  with  the Induction of Tolerance  in  T- or B-Spleen  Cells.  The 
observations that Col can act as an adjuvant and can inhibit both the induction and 
the expression of suppressor cells raise the possibility that Col might interfere with the 
induction of immunologic unresponsiveness.  However,  the  data  presented  above 
indicate that  the  injection of Col  3  h  after  DHGG  does  not  interfere with  the 
generation of unresponsiveness.  In Fig. 3 and Table II, spleen cells from mice injected 
with DHGG and colchicine remained unresponsive when transferred into irradiated 
recipients and challenged twice with antigen. Similarly, the unresponsive state to 
HGG was not perturbed by the incorporation of Col into the antigenic challenge of 
tolerant mice (Table III). The effect of Col on the induction of tolerance was further 
examined in intact animals with particular emphasis on splenic B cells. Mice injected 
with DHGG and Col 10, 30, or 65 d before were challenged with 400 #g of AHGG i.v. 
followed 3 h later by 25 #g of LPS and were plaqued 6 d after antigenic challenge. 
The injection of LPS with antigen into mice possessing tolerant T cells but responsive 
B cells leads to the generation of PFC to the injected antigen (49). Therefore, this 
protocol would allow the demonstration of responsive splenic B ceils at a time when 
splenic T cells are unresponsive to this antigen and would result in the stimulation of 
HGG-specific  B cells if Col interferes with the induction of tolerance in these B cells. 
The responsiveness of the total spleen-cell population to HGG was also investigated D.  E.  PARKS, D.  A.  SHALLER, AND W. O.  WEIGLE 
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Inability of Col to Interfere with the Induction of Tolerance to HGG 
1175 
Treatment* 
Antigenic challenge  Days posttreatment~ 
Primary  Secondary  l0  30  65 
DHGG +  Col  AHGG  AHGG~  <i  12:1:  7  8 +  5 
DHGG  AHGG  AHGG  2 +  2  3 +  2  17 +  t4 
--  AHGG  AHGG  211  =l: 78  1,366 3= 264  229 :l: 47 
DHGG +  Col  AHGG +  --  <1  25 3=  10  233 =l= 71 
LPSII 
DHGG  AHGG +  --  1 +  1  40:1:20  128±  76 
LPS 
--  AHGG  --  96 ::l: 14  180 +  19  66 +  10 
* See Table II, footnoteS. 
~: The mean =l: SE of indirect PFC/i06 cells to HGG from duplicate experiments containing four to seven 
mice per group is presented. 
§ 400 #g of AHGG was injected i.v. at various times after treatment as indicated. The mice were given a 
secondary challenge of 400 #g of AHGG i.l~. 10 d later, and individual spleens were plaqued 4 d after the 
secondary challenge. 
II 400/~g of AHGG was injected i.v. at various times after treatment as indicated. 2.5 #g of LPS was injected 
i.v. 3 h after antigenic challenge, and individual spleens were plaqued 6 d later. 
by injecting these mice with 400 #g of AHGG twice 10 d  apart and plaquing 4 d  after 
the second antigenic challenge. Table IV illustrates the inability of Col to interfere 
with the induction of tolerance in splenic T  cells as illustrated by the unresponsiveness 
observed when mice tolerized with DHGG and Col are challenged with antigen alone. 
Furthermore,  the  addition  of  LPS  to  the  antigenic  challenge  does  not  alter  the 
reacquisition of HGG-responsive splenic B  cells in  mice tolerized with  DHGG  and 
Col  as compared  to  mice  tolerized with  DHGG  alone.  By  65  d  after  tolerization, 
substantial numbers of HGG-responsive B  cells are present in both animals tolerized 
with and without Col. Nevertheless, tolerance is still persistent in T  cells as assayed by 
challenge  with  AHGG  alone.  Therefore,  although  Col  interferes  with  both  the 
generation and expression of suppressor cells specific for HGG, it does not appear to 
interfere with the induction or duration of unresponsiveness to this antigen in either 
the splenic T- or B-cell population assayed in situ (Table IV) or by adoptive transfer 
to irradiated recipients (Table II and Fig. 3). 
Inability of Col to Terminate  Tolerance  to HGG.  The unresponsive state to HGG  is of 
much  shorter duration  in bone marrow  (50)  and  splenic (12,  51)  B  cells than  in T 
cells as illustrated by Table IV.  It has been  proposed that  unresponsiveness  of the 
whole  animal  is  maintained  in  the  face  of  responsive  B  cells  by  the  absence  of 
responsive-helper T  cells and that these T  cells are permanently inactivated or deleted 
by antigen  (tolerogen)  (50, 52).  However, responsive-helper T  cells might be present 
at such  times but prevented from cooperating with responsive B  cells by suppressor 
cells. If responsive-helper T  cells are present but inhibited by suppressor cells in this 
latter stage of immunologic unresponsiveness to HGG and if Col interferes with both 
the induction and expression of HGG-specific suppressor cells as suggested by Tables 
II and III and Fig. 3, then the injection of AHGG  and Col into such mice would be 
expected to terminate the tolerant state. Mice were injected with AHGG  and Col or 
LPS 10 or 66 d  after tolerization and plaqued 6 d  after antigenic challenge to test this 1176  INTERFERENCE  WITH  SUPPRESSOR  CELLS  BY  COLCHICINE 
TABLE V 
Inability of Col to Terminate Tolerance to HGG 
Days post-  Immune status  Antigenic challenge*  PFC/106 to 
tolerization  HGG:~ 
I0  Tolerant§  AHGG +  Col  3  ±  1 
10  Tolerant  AHGG +  LPS  <1 
66  Tolerant  AHGG  2  ±  1 
66  Tolerant  AHGG +  Col  4  ±  1 
66  Tolerant  AHGG +  LPS  330  ±  52 
Normal  AHGG  62  ±  19 
* 400 #g of AHGG was injected i.v. either  10 or 66 d after tolerization.  25 #g 
of Col or LPS was injected i.v. 3 h after antigenic challenge as indicated, and 
individual spleens were plaqued 6 d later. 
:]: The mean ±  SE of indirect PFC from five mice per group is presented. 
§ 2.5 mg of DHGG was injected i.p. on day 0. 
possibility. As demonstrated in Table V, 66 d  after tolerization HGG-responsive B 
cells are detected in tolerant mice by the injection of LPS and AHGG. However, the 
injection of Col and antigen does not terminate tolerance in these mice. Neither Col 
nor LPS have any effect upon the unresponsive state in the cells of day-10 tolerant 
animals.  These data  suggest  that  interference with  the  induction  or expression of 
suppressor cells is not sufficient to allow the termination of tolerance, even in mice 
possessing responsive B cells, and indicate that unresponsiveness to HGG in helper T 
cells is not maintained by Col-sensitive-suppressor cells. 
Discussion 
The data presented in this report demonstrate that Col can interfere with suppressor 
cells specific for the soluble protein antigen HGG. Col prevents the generation of the. 
antigen-specific-suppressor cells induced by the tolerogenic form of this antigen when 
the drug is injected within hours of tolerization. Furthermore, the expression of these 
suppressor cells is inhibited when Cot is utilized during the assessment of the suppressor 
cells  previously induced with  tolerogen. This  interference with  the  induction  and 
expression of antigen-specific-suppressor cells may be the mechanism of the adjuvant 
activity previously attributed to Col. As early as  1954  (46, 53), Col was reported to 
enhance serum antibody of rabbits injected with diphtheria toxoid. Since these initial 
observations, several workers have reported similar enhancement of humoral antibody 
responses mediated by Col in rabbits  (54), hamsters  (55,  56), guinea pigs  (57), and 
mice (37, 47)  to a  variety of antigens.  Recently, Shek et al.  (37)  have demonstrated 
that  Col  can  act  as  an  adjuvant  for  the  PFC  response  to  the  random,  synthetic 
copolymer  of  L-glutamic  acidS°-L-tyrosine  5°  by  interfering  with  the  induction  of 
suppressor cells to this synthetic peptide antigen.  The data presented here confirm 
and extend these previous reports by demonstrating that the induction of suppressor 
cells specific for a naturally occurring protein antigen, HGG, can be abrogated with 
Col and that the expression of existing, mature suppressor cells can also be inhibited 
by this agent. 
The ability of Col  to block the  activity of suppressor cells and  thereby increase 
immune responsiveness may exemplify a class of immunopotentiating agents defined D.  E. PARKS, D. A. SHALLER, AND W.  O. WEIGLE  1177 
by their mechanism of adjuvant action. In addition to Col, irradiation  (38-41) and 
other pharmacological  agents  including  corticosteroids  (32-35),  cyelophosphamide 
(27-31), and indomethaein (36) have been reported to serve as adjuvants for humoral 
and cellular-immune responses possibly by interfering with suppressor cells.  Of these 
agents that may selectively inhibit suppressor cells, Col may have the greatest potential 
for use as  an  adjuvant.  With  the  exception of Col,  these  agents  possess  adjuvant 
activity over a  narrow dose range and are more widely recognized as potent immu- 
nodepressants (58). In contrast, in the present studies, Col did not depress immune 
responsiveness when injected up to 24 h before assessment of the PFC response (Figs. 
1 and 2), and it has been reported to be immunodepressive in vivo only when injected 
repeatedly (59, 60) or at nearly toxic doses (61, 62). In the present work as in previous 
reports  (46,  47),  Col  possessed  adjuvant  properties at  concentrations approaching 
toxicity, and at concentrations that were toxic for individual animals, the surviving 
animals exhibited heightened immune responses. 
The mechanism by which Col inhibits suppressor cells is unclear. However, it has 
been  suggested  that  the  selective inhibition  of suppressor cells  is  due  to  the  anti- 
mitotic  activity of Col  (37,  47).  This  postulate  is  applicable  to  the  induction  of 
suppressor cells that have been demonstrated to require cell division (63)  and to be 
sensitive to irradiation (64). However, the expression of suppressor cells appears to be 
relatively more resistant to irradiation (64-67) or mitomycin C  (33).  If the effects of 
Col  upon  the  expression of mature  suppressor  cells  is  limited  to  the  anti-mitotic 
activity of this drug, then the cells directly affected by Col may be cells which amplify 
the  action  of the  mature suppressor cells.  These amplifier cells might  require cell 
division  before becoming fully competent.  T  lymphocytes that  may  augment  the 
functions of mature suppressor cells have recently been described  (24,  31, 68, 69). 
Alternatively, Col may interfere with subcellular processes associated with cell motility 
or communication, thus preventing cell-to-cell interaction between mature suppressor 
cells and their targets or intermediary lymphocytes. 
Interference with the induction of tolerance has been proposed as the most stringent 
assay for adjuvant activity (70).  However, this view can no longer be supported in 
light  of the  demonstration  that  Col  promotes  an  adjuvant  increase  in  both  PFC 
(Table I  and Fig.  1)  (47) and circulating antibody (47) to HGG even though it does 
not interfere with the induction of tolerance to this antigen (Table II and Fig. 3). This 
segregation  of the  ability  to  interfere with  the  induction  of tolerance  from  other 
mechanisms  of adjuvant  activity has been  documented previously  (71)  in  athymic 
nude  mice  (19,  20)  and  in  the  LPS-nonresponder  C3H/HeJ  mouse  (72),  with 
polymerized flagellin (19), LPS (20), and lipid A-associated protein (72). 
A final area of interest arises from the inability of Col to interfere with the induction 
of tolerance although successfully interfering with the generation of suppressor cells. 
These data have direct implications on the putative role of suppressor cells in  the 
tolerant state. Although the unresponsiveness established by the injection of DHGG 
and  Col  lacks  demonstrable  levels of suppressor  cells,  this  tolerant  state  is:  (a)  as 
complete  as  in  animals  receiving  tolerogen  alone;  (b)  stable  upon  adoptive  cell 
transfer;  (c) persistent in splenic T  lymphocytes for at least 66 d;  (d)  established in 
splenic  B  lymphocytes  as  assessed  by  challenge  with  antigen  and  LPS;  and  (e) 
maintained  in  B  cells with  the  same  kinetics  as  animals  receiving only tolerogen. 
Furthermore,  interference with  suppressor  cells  by  Col  was  unable  to  terminate 1178  INTERFERENCE WITH SUPPRESSOR CELLS BY COLCHICINE 
tolerance. This ability to induce and maintain immunologic unresponsiveness to HGG 
in the absence of antigen-specific suppressor cells is in agreement with previous reports 
(17,  73)  and confirms the demonstration that suppressor ceils are not  necessary for 
this tolerant state. As suggested previously (52, 73), tolerance to HGG may exemplify 
a state of central or intrinsic unresponsiveness in which antigen-responsive B cells are 
irreversibly inactivated or permanently deleted. The data presented here support this 
postulate.  Suppressor  cells  do  not  appear  to  be  responsible  for  the  induction  of 
unresponsiveness  in  either  T  or  B  lymphocytes  to  HGG  nor  do  they  appear  to 
influence the duration of tolerance in these ceils. Similar conclusions have been drawn 
from systems in which tolerance is established in B cells in vitro (74, 75). 
The tenuous association of suppressor cells with the unresponsive state to soluble 
protein antigens has been suggested by others (73). Suppressor cells are only transiently 
associated with the unresponsive state established to HGG (6, 48) and do not appear 
to be required for the maintenance of tolerance in either T  or B lymphocytes (17). 
Furthermore, new suppressor cells cannot be induced in unresponsive mice after the 
disappearance of the initial, transient suppressor ceils (16) speaking against a role for 
suppressor cells in states of unresponsiveness to persistent self-antigens. Unresponsive- 
ness can be established in the absence of transient suppressor-cell activity (a) in adult 
animals by tolerizing with a  low dose of commercially acquired HGG (16)  or with 
HGG purified from either individual volunteers or myeloma patients  (17); or (b) in 
neonatal animals  (18).  Unresponsiveness lacking suppressor cells has  also been  re- 
ported in adult animals  (12-14) with the conventional DAGG tolerization protocol. 
The demonstration that tolerance can be induced in congenitally athymic nude mice 
devoid of competent T  cells with both immunogenic  (21)  and  tolerogenic (19,  20) 
forms of heterologous gamma globulins and in adult  thymectomized, X-irradiated, 
bone marrow-reconstituted mice (4,  13) further support the postulate that tolerance 
can be induced in the absence of suppressor T  cells. These observations coupled with 
the  demonstration  of the  presence  of antigen-specific-suppressor cells  to  HGG  in 
primed mice (23) and the more efficient suppression of HGG-primed cells compared 
to  normal  cells  (76)  suggest  that  these  suppressor  cells  may  represent  a  normal 
regulatory mechanism operative during antigenic stimulation although their relevance 
to the unresponsive state to HGG must  remain  dubious. The existence of antigen- 
specific-suppressor cells in an animal immunologically unresponsive to that antigen 
does not  in  itself imply a  causal  relationship  between  the suppressor cells and  the 
establishment and maintenance of the tolerant state. Any postulate that the suppressor 
cells present in a tolerant host represent the mechanism of unresponsiveness must be 
firmly established experimentally. 
Summary 
The ability of colchicine  (Col)  to  interfere with  suppressor cells specific for the 
soluble protein  antigen  human  gamma  globulin  (HGG)  has  been  examined.  This 
interference may be the  mechanism  of the  adjuvanticity promoted by Col.  When 
injected  into  A/J  mice  at  the  appropriate  time  and  concentration,  both  Col  and 
cyclophosphamide promoted an adjuvant increase in the plaque-forming cell response 
to  100/~g of immunogenic, aggregated HGG. Col abrogated both the induction of 
suppressor cells when injected within 3 h of tolerization with deaggregated (DHGG) 
and  the  expression  of previously induced  suppressor  cells  when  injected  with  the D.  E.  PARKS, D. A.  SHALLER, AND W.  O. WEIGLE  1179 
antigenic  challenge.  Interference  with  the  generation  and  expression  of antigen- 
specific-suppressor cells had  no detectable effect on the immunologic unresponsive 
state to HGG. Col did not interfere with the induction of tolerance at a  dose (1 mg/ 
kg)  that  abolished  the  generation  of suppressor cells.  Furthermore,  the  absence of 
colchicine-sensitive-suppressor  cells  during  the  establishment  of tolerance  had  no 
observable  effect  on  the  duration  of unresponsiveness  in  either  helper  T-  or  B- 
lymphocyte populations. Finally, Col was not able to terminate the unresponsive state 
established by DHGG even when responsive splenic B cells could be demonstrated in 
tolerant  animals. These data  indicate that suppressor cells are not  required  for the 
establishment and maintenance of the unresponsive state to this antigen. 
We thank Barbara Dunbar without whose efforts and devotion this work would not have been 
possible, Margaret Stone for her help in the completion of this manuscript, and Ann Stevens 
and Karen Prescott for their preparation of the illustrations. 
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